---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042934"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2026-09-16T20:50:37+00:00"
generated_at: "2026-09-16T20:52:06.760043+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Ernexa Therapeutics appoints Robert J. Spiegel, M.D. to board of directors

## Summary
- Appointment effective September 14, 2026; Dr. Spiegel serves until next election or earlier departure.
- Compensation follows Board of Directors Compensation Plan adopted August 15, 2026, per Q2 10-Q.
- No arrangements, family relationships, or Item 404(a) reportable transactions disclosed.

## SEC filing metadata
- accession: 0001493152-26-042934
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2026-09-16T20:50:37+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000149315226042934/0001493152-26-042934-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000149315226042934/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042934
- JSON: https://secwatch.observer/filing/0001493152-26-042934.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042934.txt

## Key facts
- Executive change
  Robert J. Spiegel was appointed as Director at Ernexa Therapeutics Inc..
  - Action: appointed
  - Role: Director
  source text: approved the appointment of Robert J. Spiegel, M.D. to serve as a member of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000149315226042934/0001493152-26-042934-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.